المؤلفون: M. Zastrozhin S., A. Sorokin S., T. Agibalova V., I. Bedina A., E. Grishina A., A. Antonenko P., I. Rozochkin N., T. Galaktionova E., I. Barna V., V. Skryabin Yu., A. Orlova V., A. Aguzarov D., L. Savchenko M., E. Bryun A., D. Sychev A., М. Застрожин С., А. Сорокин С., Т. Агибалова В., И. Бедина А., Е. Гришина А., А. Антоненко П., И. Розочкин Н., Т. Галактионова Е., И. Барна В., В. Скрябин Ю., А. Орлова В., А. Агузаров Д., Л. Савченко М., Е. Брюн А., Д. Сычев А.

المصدر: Medical Genetics; Том 18, № 1 (2019); 13-24 ; Медицинская генетика; Том 18, № 1 (2019); 13-24 ; 2073-7998

مصطلحات موضوعية: персонализированная медицина, фармакогенетика, CYP2D6, CYP2C19, CYP3A5, система поддержки принятия решений, транквилизаторы, бензодиазепины, синдром отмены алкоголя, personalized medicine, pharmacogenetics, decision support system, tranquilizers, benzodiazepines, alcohol withdrawal syndrome

وصف الملف: application/pdf

Relation: https://www.medgen-journal.ru/jour/article/view/621/397; Sachdeva A., Choudhary M., Chandra M. Alcohol Withdrawal Syndrome: Benzodiazepines and Beyond. J. Clin. Diagn. Res. 2015; 9 (9): VE01-VE07. doi:10.1016/j.drugalcdep.2005.04.011.; Weintraub S.J. Diazepam in the Treatment of Moderate to Severe Alcohol Withdrawal. CNS Drugs 2017; 31 (2): 87-95. doi:10.1007/s40263-016-0403-y.; Kattimani S., Bharadwaj B. Clinical management of alcohol withdrawal: A systematic review. Ind. Psychiatry J. 2013; 22 (2): 100-108. doi:10.4103/0972-6748.132914.; Mayo-Smith M.F. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. JAMA 1997; 278 (2): 144-151.; Dean L. Diazepam Therapy and CYP2C19 Genotype. Medical Genetics Summaries. Bethesda (MD): National Center for Biotechnology Information (US) 2012.; Inomata S., Nagashima A., Itagaki F. CYP2C19 genotype affects diazepam pharmacokinetics and emergence from general anesthesia. Clin. Pharmacol. Ther. 2005; 78: 647-655. doi:10.1016/j.clpt.2005.08.020.; Singh A.B. Improved Antidepressant Remission in Major Depression via a Pharmacokinetic Pathway Polygene Pharmacogenetic Report. Clinical Psychopharmacology and Neuroscience 2015; 13 (2): 150-156. doi:10.9758/cpn.2015.13.2.150.; Fagerness J., Fonesca E., Hess G.P. Pharmacogenetic-guided psychiatric intervention associated with increased adherence and cost savings. The Amercian Journal of Managed Care 2014; 20 (5): e146-e156.; Brener S., Holubowich C. Pharmacogenomic Testing for Psychotropic Medication Selection: A Systematic Review of the Assurex GeneSight Psychotropic Test. Ontario Health Technology Assessment Series 2017; 17 (4): 1-39.; Elliott L.S., Henderson J.C., Neradilek M.B., Moyer N.A., Ashcraft K.C., Thirumaran R.K. Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial. PLoS One 2017; 12 (2): e0170905.; Bousman C.A., Hopwood M. Commercial Pharmacogenetic - Based Decision-Support Tools in Psychiatry. The Lancet Psychiatry 2016; (3): 585-590. doi:10.1016/S2215-0366(16)00017-1.; Hua T., Quertermous T., Beatriz R., Sharon L.R., Xiaofeng Z., Brown A., Pankow J.S., Province M.A., Hunt S.C., Boerwinkle E., Schork N.J., Risch N.J. Genetic Structure, Self-Identified Race/Ethnicity, and Confounding in Case-Control Association Studies. American Journal of Human Genetics 2005; 76: 268-275. doi:10.1086/427888.; Sullivan J.T., Sykora K., Schneiderman J., Naranjo C.A., Sellers E.M. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br. J. Addict. 1989; 84 (11): 1353-1357.; Bharadwaj B., Kattimani S. Clinical management of alcohol withdrawal: A systematic review. Industrial Psychiatry Journal 2013; 2 (22): 100-108.; Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 1983; 67 (6): 361-370.; Busner J., Targum S.D. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont) 2007; 4 (7): 28-37.; Lingjaerde O., Ahlfors U.G., Bech P., Dencker S.J., Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr. Scand. Suppl 1987; 334: 1-100.; https://www.medgen-journal.ru/jour/article/view/621

الاتاحة: https://www.medgen-journal.ru/jour/article/view/621